Nate Barin

Nate Barin has extensive work experience in regulatory affairs operations. Nate is currently serving as the Senior Director of Regulatory Affairs Operations at Fate Therapeutics Inc since June 2022. Prior to that, they worked at MEI Pharma as the Director of Regulatory Affairs Operations from July 2019 to June 2022 and as the Associate Director from September 2017 to July 2019. Nate also served at Intercept Pharmaceuticals as the Senior Manager of Regulatory Operations from February 2016 to September 2017 and as the Manager from February 2014 to February 2016. Nate's previous roles include being a Senior Publication Specialist 3 at Halozyme Therapeutics, Inc. from March 2010 to February 2014, a Senior Regulatory Affairs Associate at Amylin Pharmaceuticals from July 2005 to March 2010, and a Regulatory Specialist at Isis Pharmaceuticals from September 2004 to June 2005. Nate started their career at Pfizer, Inc. as a Regulatory Specialist in the Global Regulatory Operations from January 2001 to December 2003 and as an Electronic Publishing Specialist in the Electronic Submissions Group from October 1998 to January 2001.

Nate Barin obtained a BA degree in Psychology from The Ohio State University.